Descriptions : Eskayef Pharmaceuticals Ltd (also known as SK+F) is one of Bangladesh's leading research-driven pharmaceutical companies and a major enterprise within Transcom Group. The company traces its origins to 1979 when it was established as the Bangladesh subsidiary of US multinational SmithKline & French (SK&F). In 1990, Transcom Group acquired SK&F's local operations—marking the first acquisition of a multinational enterprise by a Bangladeshi corporate entity—and renamed it Eskayef. Operating state-of-the-art facilities certified by US FDA, UK MHRA, EU GMP, and TGA Australia, Eskayef produces advanced healthcare solutions and exports formulations to over 65 countries across Asia, Europe, Africa, Australia, and the Americas.
Ceo Name : Simeen Rahman
Fax Number : +88029887373
Date of Register : 1979-11-08
Business Type : B2B,B2C
Country : Bangladesh
Goods And Services : Pharmaceutical formulations (tablets, capsules, syrups, liquids, topicals), high-tech injectables, biotech products, oncology drugs, eye drops, animal health and nutrition products, active pharmaceutical ingredients (APIs), and specialized biologicals.
Isic Code : C21 (Manufacture of basic pharmaceutical products and pharmaceutical preparations)
Affiliated Or Subsidiary Companies : N/A
All monetary figures, including Revenue, Export, Import , and Total Assets, are expressed in Millions of Dollars.
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue:300
Export:0
Import:0
Assets:380
Company Profile | ICCRS - Transparency, Participation, Development.
